These cells were initially characterized as CD138+IL10+ cells that exhibited increased expression of the inhibitory receptors LAG3, CD200, PD-L1, and PD-L2 as compared to CD138+IL10- cells and were the predominant source of IL-10 produced in response to infection. The gene discussed is PDCD1LG2; the disease is infection.